Daniel Poon

925 total citations
17 papers, 539 citations indexed

About

Daniel Poon is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Daniel Poon has authored 17 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Daniel Poon's work include Melanoma and MAPK Pathways (9 papers), Synthesis and biological activity (5 papers) and Computational Drug Discovery Methods (3 papers). Daniel Poon is often cited by papers focused on Melanoma and MAPK Pathways (9 papers), Synthesis and biological activity (5 papers) and Computational Drug Discovery Methods (3 papers). Daniel Poon collaborates with scholars based in United Kingdom, Switzerland and United States. Daniel Poon's co-authors include Rohit Srinivasan, Keerthini Muthuswamy, Ashik Amlani, Cherry Sit, Valerie Ng, Robert M. Rodriguez, Jonathan Fortman, Kristin M. Brinner, Wooseok Han and Patrick S. Lee and has published in prestigious journals such as Cancer Research, Ophthalmology and The Journal of Urology.

In The Last Decade

Daniel Poon

17 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Poon United Kingdom 10 254 151 101 83 71 17 539
Sandra F. Jones United States 7 88 0.3× 73 0.5× 122 1.2× 44 0.5× 209 2.9× 11 588
Ahmad R. Al‐Qudimat Qatar 10 46 0.2× 24 0.2× 52 0.5× 29 0.3× 15 0.2× 50 384
Nazi Torabi Canada 11 29 0.1× 99 0.7× 123 1.2× 99 1.2× 22 0.3× 27 689
Paola Daniore Switzerland 8 227 0.9× 141 0.9× 17 0.2× 69 0.8× 146 2.1× 20 570
Meliha Yetişgen United States 13 95 0.4× 108 0.7× 206 2.0× 85 1.0× 348 4.9× 53 641
Pierre Elias United States 11 96 0.4× 57 0.4× 108 1.1× 30 0.4× 114 1.6× 28 460
Elizabeth S. John United States 12 21 0.1× 120 0.8× 60 0.6× 114 1.4× 30 0.4× 49 501
Antonio Oliva Italy 10 32 0.1× 49 0.3× 26 0.3× 44 0.5× 9 0.1× 39 327
Dara Bracken‐Clarke United States 7 93 0.4× 63 0.4× 72 0.7× 17 0.2× 73 1.0× 19 351
Suyog Shetty India 2 283 1.1× 121 0.8× 23 0.2× 36 0.4× 116 1.6× 6 482

Countries citing papers authored by Daniel Poon

Since Specialization
Citations

This map shows the geographic impact of Daniel Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Poon more than expected).

Fields of papers citing papers by Daniel Poon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Poon. The network helps show where Daniel Poon may publish in the future.

Co-authorship network of co-authors of Daniel Poon

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Poon. A scholar is included among the top collaborators of Daniel Poon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Poon. Daniel Poon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sit, Cherry, et al.. (2020). Attitudes and perceptions of UK medical students towards artificial intelligence and radiology: a multicentre survey. Insights into Imaging. 11(1). 14–14. 302 indexed citations
2.
Warren, Hannah, Daniel Poon, Rohit Srinivasan, et al.. (2020). Non-contrast computed tomography characteristics in a large cohort of cystinuria patients. World Journal of Urology. 39(7). 2753–2757. 5 indexed citations
3.
Poon, Daniel, Simon J. Crabb, Robert H. Jones, et al.. (2020). Immune checkpoint inhibitor induced large vessel vasculitis. BMJ Case Reports. 13(5). e233496–e233496. 13 indexed citations
4.
Poon, Daniel, et al.. (2020). MP36-16 NON-CONTRAST COMPUTED TOMOGRAPHY CHARACTERISTICS IN A LARGE COHORT OF CYSTINURIA PATIENTS. The Journal of Urology. 203(Supplement 4). 1 indexed citations
5.
Poon, Daniel, Simon J. Crabb, Robert H. Jones, et al.. (2020). Republished: Immune checkpoint inhibitor induced large vessel vasculitis. Drug and Therapeutics Bulletin. 59(2). 29–31. 1 indexed citations
6.
Poon, Daniel, et al.. (2020). The pursuit of radiology training in times of a pandemic. BJR|Open. 2(1). 20200039–20200039. 2 indexed citations
7.
Poon, Daniel, et al.. (2019). The pedagogical power of context: extending the Epidemiology of Eyam. Physics Education. 55(1). 15021–15021. 1 indexed citations
8.
Smith, Aaron, Zhi‐Jie Ni, Daniel Poon, et al.. (2017). Imidazo[1,2-a]pyridin-6-yl-benzamide analogs as potent RAF inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(23). 5221–5224. 8 indexed citations
9.
Bagdanoff, Jeffrey T., et al.. (2015). Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase. Bioorganic & Medicinal Chemistry Letters. 25(18). 3788–3792. 21 indexed citations
10.
Poon, Daniel, Ehud Reich, Victoria M. Smith, et al.. (2015). Ruthenium-106 Plaque Brachytherapy in the Primary Management of Ocular Medulloepithelioma. Ophthalmology. 122(9). 1949–1951. 9 indexed citations
11.
Bagdanoff, Jeffrey T., Wooseok Han, Daniel Poon, et al.. (2015). Ligand efficient tetrahydro-pyrazolopyridines as inhibitors of ERK2 kinase. Bioorganic & Medicinal Chemistry Letters. 25(17). 3626–3629. 14 indexed citations
12.
Subramanian, Sharadha, Joelle Verhagen, Christopher M. McBride, et al.. (2015). Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma. ACS Medicinal Chemistry Letters. 6(9). 961–965. 35 indexed citations
13.
Subramanian, Sharadha, Abran Costales, Barry H. Levine, et al.. (2014). Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors. ACS Medicinal Chemistry Letters. 5(9). 989–992. 11 indexed citations
14.
Nagel, Tobi, Kevin Shoemaker, Nanxin Li, et al.. (2010). Abstract 20: Raf kinase inhibitors can induce Raf dimerization, downstream signaling, and cell growth. Cancer Research. 70(8_Supplement). 20–20. 2 indexed citations
15.
Brinner, Kristin M., et al.. (2009). Scalable Synthesis of β-Amino Esters via Reformatsky Reaction with N-tert-Butanesulfinyl Imines. Synlett. 2009(6). 991–993. 20 indexed citations
16.
Rodriguez, Robert M., et al.. (2008). Food, Shelter and Safety Needs Motivating Homeless Persons' Visits to an Urban Emergency Department. Annals of Emergency Medicine. 53(5). 598–602.e1. 76 indexed citations
17.
Amiri, Payman, Mina Aikawa, Darrin D. Stuart, et al.. (2006). CHIR-265 is a potent selective inhibitor of c-Raf/B-Raf/mutB-Raf that effectively inhibits proliferation and survival of cancer cell lines with Ras/Raf pathway mutations. Cancer Research. 66. 1140–1140. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026